(BBUS) JPMorgan BetaBuilders U.S. - Ratings and Ratios
Equity, Large-Cap, Mid-Cap, ETF
Dividends
| Dividend Yield | 1.09% |
| Yield on Cost 5y | 2.13% |
| Yield CAGR 5y | 6.90% |
| Payout Consistency | 98.9% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 11.8% |
| Value at Risk 5%th | 20.3% |
| Relative Tail Risk | 5.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 0.22 |
| CAGR/Max DD | 1.15 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.359 |
| Beta | 0.963 |
| Beta Downside | 0.981 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.01% |
| Mean DD | 2.21% |
| Median DD | 1.04% |
Description: BBUS JPMorgan BetaBuilders U.S. November 06, 2025
The JPMorgan BetaBuilders U.S. Equity ETF (BBUS) tracks a free-float-adjusted market-cap weighted index of U.S. stocks, covering roughly 85 % of the total market capitalization and focusing on large- and mid-cap companies. The fund’s mandate requires it to hold at least 80 % of its assets in securities that are constituents of this index, thereby delivering broad exposure to the U.S. equity market while maintaining a “large blend” style.
As of the latest filing, BBUS carries an expense ratio of 0.08 %, positioning it among the lowest-cost large-cap ETFs-a key KPI for cost-sensitive investors. The fund’s top sector weights typically align with the broader market, with information technology (~25 %), health care (~14 %), and consumer discretionary (~13 %) driving performance. Recent macro-economic drivers such as the Federal Reserve’s monetary policy stance and U.S. GDP growth trends have a material impact on the earnings outlook of these sectors, influencing BBUS’s total return potential.
For a deeper, data-driven comparison of BBUS’s valuation metrics and risk profile, you might find ValueRay’s analytical tools useful for extending your research.
What is the price of BBUS shares?
Over the past week, the price has changed by +0.51%, over one month by +0.29%, over three months by +5.56% and over the past year by +14.35%.
Is BBUS a buy, sell or hold?
What are the forecasts/targets for the BBUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 145.5 | 17.6% |
BBUS Fundamental Data Overview November 27, 2025
Beta = 1.01
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 6.25b USD (6.25b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 6.25b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 6.25b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.57% (E(6.25b)/V(6.25b) * Re(9.57%) + (debt-free company))
Discount Rate = 9.57% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BBUS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle